£2.39
0.84% day before yesterday
London, Oct 03, 05:35 pm CET
ISIN
GB00BD3VFW73
Symbol
CTEC

Convatec Group Stock price

£2.39
+0.03 1.19% 1M
-0.14 5.65% 6M
+0.22 10.14% YTD
+0.19 8.86% 1Y
+0.46 24.17% 3Y
+0.80 50.68% 5Y
+0.51 27.35% 10Y
+0.51 27.35% 20Y
London, Closing price Fri, Oct 03 2025
+0.02 0.84%

Key metrics

Basic
Market capitalization
£4.8b
Enterprise Value
£5.7b
Net debt
£923.1m
Cash
£71.0m
Shares outstanding
2.0b
Valuation (TTM | estimate)
P/E
29.9 | 18.1
P/S
2.7 | 2.6
EV/Sales
3.3 | 3.1
EV/FCF
22.7
P/B
3.5
Dividends
DPS
£0.05
Yield 1Y | 5Y
2.1% | 2.3%
Growth 1Y | 5Y
3.3% | 2.4%
Payout 1Y | 3Y
72.3% | 107.3%
Increased
1 Year
Financials (TTM | estimate)
Revenue
£1.7b | £1.8b
EBITDA
£427.9m | £479.5m
EBIT
£263.3m | £394.1m
Net Income
£160.8m | £270.6m
Free Cash Flow
£250.3m
Growth (TTM | estimate)
Revenue
7.1% | 7.1%
EBITDA
12.9% | 64.5%
EBIT
21.4% | 52.9%
Net Income
41.4% | 91.5%
Free Cash Flow
43.1%
Margin (TTM | estimate)
Gross
55.9%
EBITDA
24.5% | 26.4%
EBIT
15.1%
Net
9.2% | 14.9%
Free Cash Flow
14.3%
Financial Health
Equity Ratio
48.1%
Return on Equity
11.3%
ROCE
10.8%
ROIC
8.6%
Debt/Equity
0.7
More
EPS
£0.1
FCF per Share
£0.1
Short interest
-
Employees
10k
Rev per Employee
£160.0k
Show more

Is Convatec Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Convatec Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Convatec Group forecast:

18x Buy
86%
3x Hold
14%

Analyst Opinions

21 Analysts have issued a Convatec Group forecast:

Buy
86%
Hold
14%

Financial data from Convatec Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,748 1,748
7% 7%
100%
- Direct Costs 771 771
7% 7%
44%
977 977
7% 7%
56%
- Selling and Administrative Expenses 628 628
2% 2%
36%
- Research and Development Expense 83 83
1% 1%
5%
428 428
13% 13%
24%
- Depreciation and Amortization 165 165
2% 2%
9%
EBIT (Operating Income) EBIT 263 263
21% 21%
15%
Net Profit 161 161
41% 41%
9%

In millions GBP.

Don't miss a Thing! We will send you all news about Convatec Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions. The company was incorporated in 1978 and is headquartered in Reading, the United Kingdom.

Head office United Kingdom
CEO Karim Bitar
Employees 10,489
Founded 1978
Website www.convatecgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today